REIT - Specialty
Compare Stocks
5 / 10Stock Comparison
CCI vs WELL vs PLD vs AMT vs SBAC
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Industrial
REIT - Specialty
REIT - Specialty
CCI vs WELL vs PLD vs AMT vs SBAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Specialty | REIT - Healthcare Facilities | REIT - Industrial | REIT - Specialty | REIT - Specialty |
| Market Cap | $39.74B | $149.25B | $132.16B | $83.69B | $23.19B |
| Revenue (TTM) | $4.21B | $11.63B | $8.74B | $10.82B | $2.85B |
| Net Income (TTM) | $1.06B | $1.43B | $3.21B | $2.88B | $1.02B |
| Gross Margin | 65.7% | 39.1% | 67.7% | 73.4% | 63.6% |
| Operating Margin | 48.0% | 4.4% | 47.0% | 44.2% | 47.6% |
| Forward P/E | 43.9x | 78.4x | 41.4x | 27.4x | 29.4x |
| Total Debt | $29.57B | $21.38B | $31.49B | $44.96B | $15.32B |
| Cash & Equiv. | $269M | $5.03B | $1.32B | $1.47B | $432M |
CCI vs WELL vs PLD vs AMT vs SBAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Crown Castle Inc. (CCI) | 100 | 52.9 | -47.1% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| Prologis, Inc. (PLD) | 100 | 155.5 | +55.5% |
| American Tower Corp… (AMT) | 100 | 69.6 | -30.4% |
| SBA Communications … (SBAC) | 100 | 69.6 | -30.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCI vs WELL vs PLD vs AMT vs SBAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCI is the #2 pick in this set and the best alternative if dividends is your priority.
- 5.2% yield, vs AMT's 3.7%
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- 35.8% FFO/revenue growth vs CCI's -35.1%
PLD ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 11 yrs, beta 0.73, yield 2.6%
- 259.1% 10Y total return vs WELL's 223.1%
- 36.7% margin vs WELL's 12.3%
AMT is the clearest fit if your priority is value.
- Lower P/E (27.4x vs 41.4x), PEG 3.76 vs 3.83
SBAC is the clearest fit if your priority is valuation efficiency.
- PEG 0.25 vs PLD's 3.83
- 9.0% ROA vs WELL's 2.3%, ROIC 10.0% vs 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs CCI's -35.1% | |
| Value | Lower P/E (27.4x vs 41.4x), PEG 3.76 vs 3.83 | |
| Quality / Margins | 36.7% margin vs WELL's 12.3% | |
| Stability / Safety | Beta 0.13 vs PLD's 0.73, lower leverage | |
| Dividends | 5.2% yield, vs AMT's 3.7% | |
| Momentum (1Y) | +42.7% vs AMT's -15.0% | |
| Efficiency (ROA) | 9.0% ROA vs WELL's 2.3%, ROIC 10.0% vs 0.5% |
CCI vs WELL vs PLD vs AMT vs SBAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CCI vs WELL vs PLD vs AMT vs SBAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CCI leads in 1 of 6 categories
AMT leads 1 • SBAC leads 1 • WELL leads 1 • PLD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CCI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 4.1x SBAC's $2.9B. PLD is the more profitable business, keeping 36.7% of every revenue dollar as net income compared to WELL's 12.3%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.2B | $11.6B | $8.7B | $10.8B | $2.9B |
| EBITDAEarnings before interest/tax | $2.7B | $2.8B | $6.7B | $6.9B | $1.7B |
| Net IncomeAfter-tax profit | $1.1B | $1.4B | $3.2B | $2.9B | $1.0B |
| Free Cash FlowCash after capex | $2.7B | $2.5B | $5.2B | $3.8B | $1.0B |
| Gross MarginGross profit ÷ Revenue | +65.7% | +39.1% | +67.7% | +73.4% | +63.6% |
| Operating MarginEBIT ÷ Revenue | +48.0% | +4.4% | +47.0% | +44.2% | +47.6% |
| Net MarginNet income ÷ Revenue | +25.1% | +12.3% | +36.7% | +26.6% | +35.7% |
| FCF MarginFCF ÷ Revenue | +64.7% | +21.9% | +59.3% | +34.9% | +35.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.8% | +40.3% | +8.7% | +6.8% | +5.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +132.1% | +22.5% | -24.1% | +76.9% | -14.7% |
Valuation Metrics
AMT leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 22.3x trailing earnings, SBAC trades at a 85% valuation discount to WELL's 153.3x P/E. Adjusting for growth (PEG ratio), SBAC offers better value at 0.19x vs AMT's 4.57x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $39.7B | $149.2B | $132.2B | $83.7B | $23.2B |
| Enterprise ValueMkt cap + debt − cash | $69.0B | $165.6B | $162.3B | $127.2B | $38.1B |
| Trailing P/EPrice ÷ TTM EPS | 89.28x | 153.25x | 35.49x | 33.33x | 22.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 43.94x | 78.42x | 41.39x | 27.41x | 29.39x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.28x | 4.57x | 0.19x |
| EV / EBITDAEnterprise value multiple | 24.94x | 66.40x | 23.20x | 18.32x | 20.62x |
| Price / SalesMarket cap ÷ Revenue | 9.32x | 13.99x | 16.11x | 7.86x | 8.24x |
| Price / BookPrice ÷ Book value/share | — | 3.35x | 2.32x | 8.14x | — |
| Price / FCFMarket cap ÷ FCF | 13.82x | 52.41x | 26.90x | 22.12x | 21.74x |
Profitability & Efficiency
SBAC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
AMT delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMT's 4.34x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs CCI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +3.5% | +5.6% | +27.4% | — |
| ROA (TTM)Return on assets | +3.4% | +2.3% | +3.3% | +4.5% | +9.0% |
| ROICReturn on invested capital | +5.5% | +0.5% | +3.8% | +6.9% | +10.0% |
| ROCEReturn on capital employed | +7.2% | +0.6% | +4.8% | +8.6% | +14.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | — | 0.49x | 0.54x | 4.34x | — |
| Net DebtTotal debt minus cash | $29.3B | $16.3B | $30.2B | $43.5B | $14.9B |
| Cash & Equiv.Liquid assets | $269M | $5.0B | $1.3B | $1.5B | $432M |
| Total DebtShort + long-term debt | $29.6B | $21.4B | $31.5B | $45.0B | $15.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.17x | 0.26x | 5.27x | 3.99x | 3.65x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $6,519 for CCI. Over the past 12 months, WELL leads with a +42.7% total return vs AMT's -15.0%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs CCI's -2.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.9% | +14.3% | +11.1% | +3.8% | +14.2% |
| 1-Year ReturnPast 12 months | -9.0% | +42.7% | +39.4% | -15.0% | -7.1% |
| 3-Year ReturnCumulative with dividends | -7.3% | +189.5% | +20.8% | +3.3% | -1.0% |
| 5-Year ReturnCumulative with dividends | -34.8% | +202.3% | +37.7% | -14.7% | -18.8% |
| 10-Year ReturnCumulative with dividends | +57.9% | +223.1% | +259.1% | +113.8% | +138.9% |
| CAGR (3Y)Annualised 3-year return | -2.5% | +42.5% | +6.5% | +1.1% | -0.3% |
Risk & Volatility
Evenly matched — PLD and AMT each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMT is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than PLD's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PLD currently trades 97.8% from its 52-week high vs AMT's 76.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.26x | 0.13x | 0.73x | -0.04x | 0.16x |
| 52-Week HighHighest price in past year | $115.76 | $219.59 | $145.44 | $234.33 | $244.19 |
| 52-Week LowLowest price in past year | $75.96 | $142.65 | $103.02 | $165.08 | $162.41 |
| % of 52W HighCurrent price vs 52-week peak | +78.7% | +97.0% | +97.8% | +76.7% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 59.5 | 60.2 | 58.4 | 52.4 | 58.0 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 2.6M | 3.1M | 2.8M | 1.2M |
Analyst Outlook
Evenly matched — CCI and PLD and AMT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CCI as "Buy", WELL as "Buy", PLD as "Buy", AMT as "Buy", SBAC as "Buy". Consensus price targets imply 20.4% upside for AMT (target: $216) vs 1.5% for PLD (target: $144). For income investors, CCI offers the higher dividend yield at 5.23% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $105.40 | $226.50 | $144.43 | $216.33 | $230.14 |
| # AnalystsCovering analysts | 46 | 34 | 42 | 49 | 42 |
| Dividend YieldAnnual dividend ÷ price | +5.2% | +1.3% | +2.6% | +3.7% | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 11 | 11 | 7 |
| Dividend / ShareAnnual DPS | $4.76 | $2.76 | $3.74 | $6.73 | $4.45 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +0.0% | +0.4% | +2.1% |
CCI leads in 1 of 6 categories (Income & Cash Flow). AMT leads in 1 (Valuation Metrics). 2 tied.
CCI vs WELL vs PLD vs AMT vs SBAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CCI or WELL or PLD or AMT or SBAC a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -35. 1% for Crown Castle Inc. (CCI). SBA Communications Corporation (SBAC) offers the better valuation at 22. 3x trailing P/E (29. 4x forward), making it the more compelling value choice. Analysts rate Crown Castle Inc. (CCI) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCI or WELL or PLD or AMT or SBAC?
On trailing P/E, SBA Communications Corporation (SBAC) is the cheapest at 22.
3x versus Welltower Inc. at 153. 3x. On forward P/E, American Tower Corporation is actually cheaper at 27. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SBA Communications Corporation wins at 0. 25x versus Prologis, Inc. 's 3. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CCI or WELL or PLD or AMT or SBAC?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -34. 8% for Crown Castle Inc. (CCI). Over 10 years, the gap is even starker: PLD returned +259. 1% versus CCI's +57. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCI or WELL or PLD or AMT or SBAC?
By beta (market sensitivity over 5 years), American Tower Corporation (AMT) is the lower-risk stock at -0.
04β versus Prologis, Inc. 's 0. 73β — meaning PLD is approximately -2050% more volatile than AMT relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 4% for American Tower Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CCI or WELL or PLD or AMT or SBAC?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -35. 1% for Crown Castle Inc. (CCI). On earnings-per-share growth, the picture is similar: Crown Castle Inc. grew EPS 111. 4% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCI or WELL or PLD or AMT or SBAC?
Prologis, Inc.
(PLD) is the more profitable company, earning 45. 5% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 45. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLD leads at 53. 8% versus 3. 3% for WELL. At the gross margin level — before operating expenses — PLD leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCI or WELL or PLD or AMT or SBAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, SBA Communications Corporation (SBAC) is the more undervalued stock at a PEG of 0. 25x versus Prologis, Inc. 's 3. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, American Tower Corporation (AMT) trades at 27. 4x forward P/E versus 78. 4x for Welltower Inc. — 51. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMT: 20. 4% to $216. 33.
08Which pays a better dividend — CCI or WELL or PLD or AMT or SBAC?
All stocks in this comparison pay dividends.
Crown Castle Inc. (CCI) offers the highest yield at 5. 2%, versus 1. 3% for Welltower Inc. (WELL).
09Is CCI or WELL or PLD or AMT or SBAC better for a retirement portfolio?
For long-horizon retirement investors, American Tower Corporation (AMT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
04), 3. 7% yield, +113. 8% 10Y return). Both have compounded well over 10 years (AMT: +113. 8%, PLD: +259. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCI and WELL and PLD and AMT and SBAC?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CCI is a mid-cap income-oriented stock; WELL is a mid-cap high-growth stock; PLD is a mid-cap quality compounder stock; AMT is a mid-cap income-oriented stock; SBAC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.